Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001083519 | SCV000554687 | benign | Multiple endocrine neoplasia type 4 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000515086 | SCV000609665 | likely benign | not provided | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568414 | SCV000673202 | benign | Hereditary cancer-predisposing syndrome | 2019-02-22 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000515086 | SCV001817975 | likely benign | not provided | 2020-12-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268096 | SCV002550002 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002268096 | SCV002774212 | benign | not specified | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001083519 | SCV002799421 | likely benign | Multiple endocrine neoplasia type 4 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001083519 | SCV004017036 | benign | Multiple endocrine neoplasia type 4 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000515086 | SCV004134457 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | CDKN1B: BP4, BS1 |
ARUP Laboratories, |
RCV001083519 | SCV004563320 | likely benign | Multiple endocrine neoplasia type 4 | 2023-03-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000515086 | SCV005213776 | likely benign | not provided | criteria provided, single submitter | not provided |